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Abstract
Background: Although the motile sperm organelle morphology examination (MSOME) was developed merely as a
selection criterion, its application as a method for classifying sperm morphology may represent an improvement in
the evaluation of semen quality. The aim of this study was to determine the prognostic value of normal sperm
morphology using MSOME with regard to clinical pregnancy (CP) after intrauterine insemination (IUI).
Methods: A total of 156 IUI cycles that were performed in 111 couples were prospectively analysed. Each subject
received 75 IU of recombinant FSH every second day from the third day of the cycle. Beginning on the 10th day
of the cycle, follicular development was monitored by vaginal ultrasound. When one or two follicles measuring at
least 17 mm were observed, recombinant hCG was administered, and IUI was performed 12-14 h and 36-40 h after
hCG treatment. Prior to the IUI procedure, sperm samples were analysed by MSOME at 8400× magnification using
an inverted microscope that was equipped with DIC/Nomarski differential interference contrast optics. A minimum
of 200 motile spermatozoa per semen sample were evaluated, and the percentage of normal spermatozoa in each
sample was determined.
Results: Pregnancy occurred in 34 IUI cycles (CP rate per cycle: 21.8%, per patient: 30.6%). Based on the MSOME
criteria, a significantly higher percentage of normal spermatozoa was found in the group of men in which the IUI
cycles resulted in pregnancy (2.6+/-3.1%) compared to the group that did not achieve pregnancy (1.2+/-1.7%; P =
0.019). Logistic regression showed that the percentage of normal cells in the MSOME was a determining factor for
the likelihood of clinical pregnancy (OR: 1.28; 95% CI: 1.08 to 1.51; P = 0.003). The ROC curve revealed an area
under the curve of 0.63 and an optimum cut-off point of 2% of normal sperm morphology. At this cut-off
threshold, using the percentage of normal sperm morphology by MSOME to predict pregnancy was 50% sensitive
with a 40% positive predictive value and 79% specificity with an 85% negative predictive value. The efficacy of
using the percentage of normal sperm morphology by MSOME in predicting pregnancy was 65%.
Conclusions: The present findings support the use of high-magnification microscopy both for selecting
spermatozoa and as a routine method for analysing semen before performing IUI.
Background
Intrauterine insemination (IUI) is a simple and non-inva-
sive procedure that is used to treat couple subfertility. In
many cases, IUI allows one to avoid more complex
assisted reproduction techniques (ART) such as in vitro
fertilization (IVF) and intracytoplasmic sperm injection
(ICSI). On the other hand, IUI yields varied results as a
consequence of the large number of variables that are
involved in the treatment, including the aetiology of
infertility, the age of the couple, ovarian stimulation pro-
tocols, timing and number of inseminations; this has
raised doubts regarding the actual effectiveness of IUI
[1]. The most common indications for IUI are cervical
hostility, mild male factor, mild endometriosis, ovarian
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dysfunction, and unexplained infertility [2]. In regard to
male infertility, there is insufficient information regarding
the effectiveness of IUI, and more data are required to
either recommend or advise against IUI in these situa-
tions [3]. Because one of the most common indications
for IUI is mild male factor, and in view of the doubts
regarding the efficacy of the procedure with respect to
this indication, it would be of high clinical interest to
determine the semen parameters that could serve as pre-
dictive factors.
Innovative methods for the selection of sperm in ART
[4-9] have been published, providing fresh insight into
the correlation between sperm quality and clinical
results. On the other hand, the value of conventional
semen analysis has been the subject of debate. By analys-
ing semen, clinicians expect to obtain a clear indication
of the male’s fertilisation potential, which is not provided
by conventional evaluation (except in particular situa-
tions such as total teratozoospermia and globozoosper-
mia) [10,11]. Although none of the semen parameters (or
even the functional test)–analysed either separately or
jointly–can be considered definitive, morphology has
been consistently shown to be the most reliable indicator
of male fertility. Diverse studies that originated primarily
from IVF/ICSI programmes and IUI corroborate the sen-
sitivity of morphology as a prognostic factor [10-20].
To test the hypothesis that subtle sperm organelle mal-
formations [21,22] are associated with ART results,
Bartoov et al. [23,24] developed a method of evaluating
human spermatozoa in real-time at high magnification;
this method is called the motile sperm organelle morphol-
ogy examination (MSOME). MSOME is performed using
an inverted microscope that is equipped with differential
interference contrast/Nomarski optics that enable magnifi-
cation exceeding 6000× [23], which is much higher than
the magnification that is typically used by embryologists in
selecting spermatozoa for the ICSI procedure (which
ranges from 200× to 400×) and is even higher than that
which is employed in routine semen examination (1000×).
This method favoured the development of intracytoplas-
mic morphologically selected sperm injection (IMSI),
which is based on sperm normality–as defined by the
MSOME classification–and is aimed at improving conven-
tional ICSI outcomes by focusing on the existence of a cor-
relation between both sperm morphological abnormalities
that can be observed at high magnification and DNA
damage [24-28]. Although MSOME was developed merely
as a selection criterion, its application as a method for clas-
sifying sperm morphology may represent an improvement
in the evaluation of semen quality. In the specific case of
IUI, seminal evaluation using MSOME could represent an
adjunct tool to predict the efficacy of the technique.
To better comprehend the diagnostic/prognostic value
of analysing semen morphology using high magnification,
this study aimed to evaluate the prognostic value of
normal sperm morphology using MSOME classification
in predicting clinical pregnancy (CP) after IUI.
Methods
Study participants
A total of 156 IUI cycles that were performed in 111 cou-
ples at the Center for Human Reproduction Professor
Franco Junior were prospectively analysed. The mean
ages of the female and male subjects at the time of the
IUI cycles were 32.7 ± 3.9 and 35.4 ± 5.6 years, respec-
tively. The indications for IUI included idiopathic inferti-
lity in 51.4%, mild male infertility in 23.4%, cervical factor
in 15.3%, ovulatory dysfunction in 5.4%, mild endome-
triosis in 3.6%, and male factor associated with endome-
triosis in 0.9% of the cases (Table 1). Written informed
consent was obtained from all couples on the day of the
first IUI cycle. This study received institutional review
board approval.
IUI procedures
For ovarian stimulation, each female subject received 75
IU of recombinant FSH (r-FSH; Gonal F, Serono, Brazil)
every second day from the third day of the cycle. Begin-
ning on the 10th day of the cycle, follicular development
was monitored by vaginal ultrasound, and the dose of
r-FSH was changed based on the ovarian response.
When one or (at most) two follicles measuring at least
17 mm were observed, recombinant hCG (r-hCG;
Ovidrel, Serono, Brazil) was administered.
Each patient underwent two consecutive IUI proce-
dures (12-14 h and 36-40 h after r-hCG). Semen samples
were collected into sterile containers by masturbation
and immediately used for the IUI procedures. Liquefied
fresh semen samples were prepared with an Isolate dis-
continuous concentration gradient (Irvine Scientific,
Santa Ana, CA, USA). The final pellet was resuspended
in 0.5 and 0.3 ml modified HTF medium (Irvine Scienti-
fic) that was supplemented with 10% human serum albu-
min (Irvine Scientific) for the first (12-14 h) and second
(36-40 h) inseminations.
All of the IUI procedures were performed using a Fryd-
man catheter (Frydman Classic Catheter 4.5 CCD Labora-
toire CCD; Paris, France) guided by abdominal ultrasound
using a 3.5 MHz convex transducer (Aloka SSD-1100;
Aloka Co. Ltd., Tokyo, Japan) by the same physician.
Patients with a full bladder were placed in the lithotomy
position, and the cervix was exposed using a bivalve specu-
lum. For all of the IUI procedures, the catheter passed
smoothly through the cervix (without the need for uterine
fixation clamps) with clear visualisation of the catheter tip
upon ultrasound. In each insemination, the medium con-
taining the spermatozoa was gently expelled into the uter-
ine cavity under ultrasound monitoring. Following IUI, the
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catheter was immediately and carefully removed, and the
patient was allowed to rest in bed for 15 min. Each patient
received luteal phase supplementation with vaginal natural
progesterone.
Pregnancy was diagnosed based on an increase in
serum ß-hCG concentration 14 days after IUI. Clinical
pregnancy was defined as the presence of a gestational
sac that was accompanied by an image of the embryo/
fetal cardiac activity on transvaginal ultrasound 4 weeks
after IUI.
Determination of sperm morphology by MSOME
Before the IUI procedure, semen samples were analysed
for standard semen quality parameters according to the
World Health Organization [29] using MSOME and for
DNA fragmentation using the TUNEL assay as previous
described [30,31]).
For MSOME, the liquefied fresh semen samples were
prepared using the Isolate discontinuous concentration
gradient (Irvine Scientific). The final pellet was resus-
pended in 0.2 ml modified human tubal fluid (HTF)
medium (Irvine Scientific). A 1-μl aliquot of the sperm
cell suspension was transferred to a 5-μl microdroplet of
modified HTF medium containing 7% polyvinylpyrroli-
done solution (PVP medium; Irvine Scientific). This
microdroplet was placed in a sterile glass dish (FluoroD-
ish; World Precision Instruments, USA) under sterile
paraffin oil (Ovoil-100; VitroLife, Göteborg, Sweden).






Women’s age (years) Mean ± SD 32.8 ± 3.9 32.3 ± 4.0 32.9 ± 3.9 0.45
Range 24-39 25-39 24-39
Median 33 33 33
Men’s age (years) Mean ± SD 35.5 ± 5.6 34.9 ± 5.0 35.5 ± 5.7 0.59
Range 24-50 27-48 24-50
Median 34 35 34
Duration of infertility (years) Mean ± SD 2.8 ± 1.9 2.4 ± 1.9 2.9 ± 1.9 0.25
Range 1-13 1-10 1-13
Median 2 2 2
MSOME (%)
-Normal spermatozoa Mean ± SD 1.5 ± 2.2 2.6 ± 3.1 1.2 ± 1.2 0.019
Range 0-13 0-13 0-13
Median 1 1.5 0.5
Follicles ≥17 mm (n) Mean ± SD 1.2 ± 0.4 1.2 ± 0.4 1.2 ± 0.4 0.64
Range 1-2 1-2 1-2
Median 1 1 1
Aetiology
-Idiopathic 51.4%(57/111) 46.2%(12/26) 52.9%(45/85) 0.66
-Male (mild) 23.4%(26/111) 30.8%(8/26) 21.2%(18/85)
-Cervical 15.3%(17/111) 19.2%(5/26) 14.1%(12/85)
-Ovulatory 5.4%(6/111) 3.8%(1/26) 5.9%(5/85)
-Endometriosis 3.6%(4/111) 0 4.7%(4/85)
-Male (mild) + Endometriosis 0.9%(1/111) 0 1.2%(1/85)
DNA fragmentation (%) Mean ± SD 16.4 ± 8.0 15.0 ± 7.4 16.7 ± 8.1 0.26
Range 3-37.5 5-35.5 3-37.5
Median 15 12 15
Total sperm count (x106/ml) Mean ± SD 79.2 ± 54.4 83.6 ± 43.4 78 ± 57.2 0.24
Range 5-280 15-160 5-280
Median 68.5 86 62
Motility (% spermatozoa) (rapid + slow progression) Mean ± SD 63.2 ± 15.4 59.7 ± 14.9 64.2 ± 14.5 0.12
Range 19-93 19-87 19-93
Median 63 60 66
Leukocytes (x106) Mean ± SD 0.26 ± 0.26 0.30 ± 0.28 0.25 ± 0.26 0.34
Range 0-1.6 0-1.3 0-1.6
Median 0.2 0.2 0.2
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The sperm cells that were suspended in the microdro-
plet were placed on a microscope stage above an Uplan
Apo ×100 oil/1.35 objective lens that was previously
covered with a droplet of immersion oil. In this manner,
suspended motile sperm cells in the observation droplet
were then examined under high magnification using an
inverted microscope (Eclipse TE 2000U; Nikon, Japan)
that equipped with high-power differential interference
contrast optics (DIC/Nomarski). The images were cap-
tured using a colour video camera containing effective
picture elements (pixels) for high-quality image produc-
tion and visualised on a colour video monitor. The mor-
phological evaluation was performed on a monitor
screen, and the combined calculated magnification was
8450× (total magnification: objective magnification =
100 ×; magnification selector = 1.0 ×; video coupler
magnification = 1.0 ×; calculated video magnification =
84.50).
A spermatozoon was classified as morphologically
normal when it exhibited a normal nucleus, acrosome,
postacrosomal lamina, neck and tail and did not present
a cytoplasm around the head [23]. The subcellular orga-
nelles were morphologically classified as follows on the
basis of the presence of specific malformations that
were defined according to the arbitrary descriptive
approach that was reported by Bartoov et al. [23] using
studies utilising transmission and scanning electron
microscopy: an absent, partial or vesiculated acrosome;
an absent or vesiculated post-acrosomal lamina; a neck
that was abaxial, disordered or showing a cytoplasmic
droplet; an absent, coiled, broken, multiple or short tail.
With respect to the nucleus and according to trans-
mission electron microscopy estimates [23,32], the nor-
mal morphological state was defined by the shape and
content of the chromatin. The criterion for normality of
nuclear shape was a smooth, symmetric and oval con-
figuration. Normal means for length and width were
estimated as 4.75 ± 2.8 and 3.28 ± 0.20 μm, [23],
respectively, wherein the shape was classified as abnor-
mal when measuring more than 2 SD on at least one of
the axes (length: ≥5.31 or ≤4.19 μm; width: > 3.7 or <
2.9 μm). For a rapid evaluation of nuclear shape, a
fixed, transparent, celluloid form of sperm nucleus fit-
ting the criteria was superimposed on the examined cell
(chablon construction based on ASTM E 1951-2 [33]).
The criterion for normal chromatin content was the
absence of vacuoles occupying > 4% of the sperm
nuclear area. Figure 1A shows normal spermatozoa as
analysed by MSOME.
The same technician performed all of the sperm
selections. At least 200 motile spermatozoa per sample
were evaluated, and the percentages of normal sperma-
tozoa were determined. The analysis lasted 30-60 min/
sample.
Statistical analysis
Data management and univariate analysis were performed
using the StatsDirect statistical software (Cheshire, UK) to
compare the variables between the group of cycles in
which the IUI procedure resulted in pregnancy and the
group in which the IUI procedure did not result in preg-
nancy. The analysis was performed at the cycle level (i.e.,
each cycle was considered as a separate unit for analysis).
To compare the means of the continuous variables, the
non-parametric Mann-Whitney test was used if the con-
tinuous variables were not normally distributed, and the
Student’s t-test was used if the continuous variables were
normally distributed. The results are expressed as the
arithmetic mean ± standard deviation (SD), range and
median. For categorical variables, the chi-square test was
used to check their association between groups, and the
results are expressed as a percentage. Univariate logistic
regression was also used to estimate the value of an inde-
pendent variable in predicting the likelihood of becoming
pregnant in an IUI cycle. The odds ratio (OR) and 95%
confidence interval (CI) constituted the descriptive
analysis.
Receiver operating characteristic curves (ROC) were
constructed to examine the performance of the significant
variables as identified by the previous statistical tests (i.e.,
to evaluate the ability of a variable to predict pregnancy
after an IUI cycle). An optimised threshold was deter-
mined. The discriminative performance of the model was
assessed by the area under the ROC curve. Sensitivity was
defined as the fraction of cycles that resulted in a preg-
nancy that was predicted correctly, and specificity was
defined as the fraction of cycles not resulting in a preg-
nancy that was predicted correctly. StatsDirect requires
the following two columns of data for each ROC plot: one
with test results in cases where the condition being tested
is known to be present (pregnancy positive) and the other
with test results in known negative (pregnancy negative)
cases. Sensitivity is then plotted against (1-specificity).
StatsDirect calculates directly the area under the ROC
curve using an extended trapezoidal rule [34] and
by a non-parametric method that is analogous to the
Wilcoxon/Mann-Whitney test [35]. A confidence interval
was constructed using DeLong’s variance estimate [36].
Results
Pregnancy occurred in 34 IUI cycles (CP rate per cycle:
21.8%, per patient: 30.6%). A significantly higher inci-
dence of normal spermatozoa according to the MSOME
criterion was found in the group of men in which the
IUI cycles resulted in pregnancy (2.6 ± 3.1%) compared
to the group that did not achieve pregnancy (1.2 ± 1.7%;
P = 0.019). The laboratory and clinical parameters that
were evaluated according to IUI outcome are shown in
Table 1. With the exception of the percentage of normal
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spermatozoa, there were no significant differences
between the groups.
Logistic regression revealed that the percentage of nor-
mal cells in the MSOME analysis was a determinant of the
likelihood of achieving clinical pregnancy (OR: 1.28; 95%
CI: 1.08 to 1.51; P = 0.003). On the other hand, logistic
regression did not reveal a statistically significant (P >
0.05) association between IUI outcome (CP) and the other
parameters that were analysed, including the woman’s age
(OR: 0.96; 95% CI: 0.88 to 1.06) and man’s age (OR: 0.98;
95% CI: 0.91 to 1.05), the duration of infertility (OR: 0.81;
95% CI: 0.63 to 1.03), DNA fragmentation (OR: 0.97; 95%
CI: 0.97 to 1.02), the number of follicles ≥17 mm (OR:
1.40; 95% CI: 0.53 to 5.21), and other semen characteris-
tics, including total sperm count (OR: 1.00; 95% CI: 0.99
to 1.00), progression motility (OR:0.98; 95% CI: 0.95 to
1.00), and leukocytes (OR:1.77; 95% CI: 0.46 to 6.70).
Table 2 summarises these results.
The ROC curve was created only for the percentage of
normal sperm morphology s by MSOME (which was the
only variable that differed significantly between the groups
in the previous analysis). The ROC curve (Figure 2) had
an area under the curve of 0.63 (95% CI: 0.52-0.78) (see
Methods), indicating that the percentage of normal forms
as analysed by MSOME had reasonable prognostic
potency for predicting pregnancy after IUI. Setting the
threshold at 2% offered the optimal compromise between
specificity (50%) and sensitivity (79%) and between positive
predictive value (40%) and negative predictive value (85%).
At this cut-off level, the efficacy of the percentage of nor-
mal sperm morphology by MSOME in predicting preg-
nancy was 65%.
Discussion
The rationale for the IUI procedure is to maximise the
number of motile spermatozoa at the site of fertilisation
to maximise the likelihood of achieving pregnancy.
Although IUI is used widely in the treatment of couple
subfertility, its true efficacy is yet to be determined, parti-
cularly when the technique is employed due to male sub-
fertility [1]. According to Merviel et al. [37], the most
important predictive factors for pregnancy in IUI cycles
are the recruitment of two preovulatory follicles that are
> 16 mm in a woman of age ≤30 years and a concentra-
tion ≥5 million motile spermatozoa and teratospermia
≤70% after the preparation of semen by a discontinuous
concentration gradient. Another study reported that IUI
that was performed for male factor subfertility has a low
possibility of success when the woman’s age is > 35 years,
the number of motile spermatozoa that are inseminated
is < 5 million, or normal sperm morphology–as defined
by the criteria of the World Health Organization–is <
30% [38].
On the other hand, Dorjpurev et al. [39] showed that
with a motility rate of ≥30% and a motile sperm concen-
tration of ≥10 million/ml, IUI can be a useful tool for
treating male subfertility. Kamath et al. [40] reported
that a duration of infertility of less than 5 years and a
total motile spermatozoa count of more than 10 million
are related to a better prognosis in IUI, and they found
a trend toward a higher pregnancy rate with endometrial
thickness > 6 mm. Wainer et al. [41] reported that a
minimum of 5 million motile spermatozoa should be
inseminated only when the normal morphology of the
sperm after preparation is < 30%, as the quantity com-
pensates–at least in part–for poor seminal quality; they
further noted that if these parameters cannot be
reached, in vitro fertilization should be recommended.
Other clinical parameters have also been evaluated,
including the comparison of recombinant FSH and
highly purified FSH for ovarian stimulation [42], the use
of GnRH antagonists to avoid a premature LH surge
[43,44], the association of chromatin condensation in
spermatozoa with conventional semen parameters [45],
and the use of a soft versus firm catheter for the insemi-
nation procedure [46], all of which were designed to
Figure 1 Sperm morphology. A: Normal spermatozoa observed at high magnification (8400×); B: Spermatozoa with large nuclear vacuoles
observed at high magnification (8400×).
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identify predictive factors of the likelihood of achieving
pregnancy in IUI.
Unfortunately, MSOME is not typically applied beyond
its use in sperm selection for the ICSI procedure. In fact,
to the best of our knowledge, the present study is the
first to analyse MSOME as a prognostic factor for IUI;
thus, our results cannot be compared with other results.
However, our data are in agreement with other studies
that used other morphological sperm evaluation criteria.
In fact, morphological sperm alterations seem to confer a
significantly poorer outcome in IUI [37,47,48] and are
reported to be a more relevant semen parameters than
sperm concentration and sperm motility [49]. Karabinus
and Gelety [50] stated that pregnancy rates per cycle
after IUI were not different when the percentage of mor-
phologically normal sperm (strict criteria) in raw semen
was 5%, 5-9%, 10-19%, 20-29%, or ≥30% (with rates of
6.55 ± 3.9,13.6 ± 3.2, 8.8 ± 2.4, 7.1 ± 2.5, and 9.7 ± 3.3%,
respectively). Thus, the authors concluded that IUI
appears to be a successful treatment modality for male
factor infertility even in cases in which the percentage of
morphologically normal sperm in raw semen is quite low.
On the other hand, the morphological criteria for
assessing spermatozoa quality according to parameters of
the World Health Organization were recently modified
(with a normal morphology cut-off value of > 4% in the
2010 WHO manual) [51], demonstrating that there is
still a controversy regarding the definition of a morpholo-
gically normal spermatozoon. It would be of great clinical
value to establish a laboratory parameter that could reli-
ably and more efficiently predict the outcome of IUI to
both improve the outcome and optimise the indications
of the technique. Recently, our group suggested that
MSOME should be included among the routine criteria
for semen analysis, given that it is a much stricter criter-
ion of sperm morphology classification than the Tyger-
berg criterion [27]. In addition, we also demonstrated
that MSOME appears reliable for analysing semen [52].
One of the most important alterations that can be
observed with MSOME is the presence of large nuclear
vacuoles (LNV; see Figure 1B). We consider LNV as those
that occupy more than 50% of the nuclear area [52]. LNV
Table 2 Univariate analysis of pregnancy occurrence after intrauterine insemination by logistic regression
Parameter Logistic Regression
Odds Ratio 95% CI P-value
Women’s age (years) 0.96 0.87 to 1.06 0.44
Men’s age (years) 0.98 0.91 to 1.05 0.61
Duration of infertility (years) 0.81 0.63 to 1.03 0.10
MSOME (%)
-Normal spermatozoa
1.28 1.08 to 1.51 0.003
Follicles ≥17 mm (n) 1.40 0.53 to 3.68 0.49
DNA fragmentation (%) 0.97 0.97 to 1.02 0.26
Total sperm count (x106/ml) 1.00 0.99 to 1.01 0.59
Motility (% spermatozoa)(rapid + slow progression) 0.98 0.96 to 1.01 0.13
Leukocytes (x106) (mean ± SD) 1.77 0.46 to 6.70 0.39
CI: confidence interval.
Figure 2 ROC Curve. ROC curve analysis for the percentage of
normal sperm morphology using MSOME as a prognostic factor
regarding clinical pregnancy after intrauterine insemination. The
area under the curve is 0.63. The best discriminating percentage
(2%) is indicated. At this cut-off level, the ability of the percentage
of sperm normal form by MSOME to predict pregnancy showed
50% sensitivity with a 40% positive predictive value and 79%
specificity with an 85% negative predictive value. The efficacy was
65%.
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are specific sperm alterations that can be observed at high
magnification, and their presence has been shown to have
clinical implications. Based on electron microscopy data,
Bartoov et al. [23,53] and Berkovitz et al. [32] assumed
that nuclear vacuoles indicate a chromatin abnormality.
Other studies confirmed the association between nuclear
vacuoles at high magnification and chromatin damage.
Berkovitz et al. [54] graded the severity of nuclear mor-
phological alterations, highlighting principally the presence
of large vacuoles and suggesting that vacuolisation of the
sperm nucleus reflects some underlying chromosomal or
DNA defect. Franco et al. [31,55] demonstrated an asso-
ciation between large nuclear vacuoles and the presence of
DNA fragmentation, denaturation and protamination in
the spermatozoa. Garolla et al. [56] showed that the pre-
sence of nuclear vacuoles affects mitochondrial function,
chromatin status, and aneuploidy rate. Using electron
microscopy, Toshimori and Ito [57] associated the pre-
sence and content of nuclear vacuoles with DNA damage.
In addition, the authors emphasised that IMSI/MSOME
aids in identifying vacuoles. Oliveira et al. [28] observed a
significant positive correlation between the percentage of
sperm that contain large nuclear vacuoles and the percen-
tage of DNA fragmentation. Gopalkrishnan et al. [58]
found that the chromatin material of spermatozoa from
men whose partners presented with early pregnancy loss
was often found to be either compact or partially compact
with irregular nuclear borders and large vacuoles. More-
over, a recent study has related LNV to the absence of
acrosome reaction, which could have deleterious effects
on the processes of fertilization and embryo development
[59]. On the other hand, it has been clearly established
that the capacity of human sperm to fertilise an oocyte
and produce an embryo with a high potential for implan-
tation and development depends on the sperm cell’s DNA
integrity [56]; thus, MSOME could provide important
information regarding the likelihood of success with ART.
Many investigators have reported the outcome of in
vitro fertilization techniques according to MSOME
[24,25,32,52,60-63], but this evaluation has not been
employed previously to determine the success rate of
IUI. The present study investigated the outcome of IUI
compared with semen morphology as assessed with
MSOME. We observed a significantly higher pregnancy
rate with a higher percentage of normal cells according
to the MSOME parameters. However, a logistic regres-
sion analysis failed to identify a significant correlation
between treatment outcome and other characteristics
such as patient age, duration of infertility, the number
of follicles and other semen parameters. This is in con-
trast with other published reports [1,37,39]. The lack of
consensus in the literature clearly highlights the difficul-
ties in finding reliable prognostic parameters for deter-
mining IUI outcome.
With regard to the percentage of morphologically nor-
mal spermatozoa, we observed an optimum cut-off
point of 2%. With this cut-off point, the efficacy of the
exam in predicting pregnancy following IUI reached
65%, as shown by the ROC curve. Because there are
doubts regarding the efficacy of IUI for male factor,
MSOME could also play a role as a method for the clas-
sification of sperm morphology to offer an additional
parameter for the indication of the technique. Besides
the woman’s age, the duration of infertility and the con-
centration of motile spermatozoa, which are predictive
factors that are considered to be important by other
investigators, our data suggest that 2% morphologically
normal spermatozoa at MSOME is desirable to maxi-
mise the likelihood of pregnancy following IUI.
The accuracy with which the morphological normality
of spermatozoa can be assessed depends on the resolution
power of the optical magnification system. Spermatozoa
that appear to be morphologically normal at 1000× magni-
fication may in fact have various structural abnormalities
that can only be detected at higher optical magnification
(> 6000×). Few studies have attempted to analyse
MSOME as a morphological classification method for
semen. Using MSOME, Bartoov et al. [23] reported an
incidence of sperm normality of 2.9 ± 0.5% (range 0-5%).
In our study, we found an incidence of 1.5 ± 2.2% (0-13%).
Differences with regard to the observation of nuclear
vacuoles can explain the divergence found in the normality
rates between MSOME and other morphological criteria.
Employing the Tygerberg criteria, Bar-Chama et al. [64]
analysed the number of sperm vacuoles in a series of 1,295
fresh post-processed sperm samples. They found vacuoles
in only 19.5% (253) of the samples. On the other hand,
MSOME revealed that the ejaculates of males who were
routinely referred for ICSI exhibit an average of 30-40% of
spermatozoa with vacuolated nuclei [54]. In addition,
there is divergence in the quantification (i.e., normal or
abnormal) of the presence of nuclear vacuoles. Using
MSOME, the nuclear chromatin content is considered to
be abnormal if it contained one or more vacuoles that
occupied more than 4% of the nuclear area [23]. Neverthe-
less, other criteria (for example, the Tygerberg criteria) are
much more tolerant with regard to the presence of
vacuoles. A head is considered to be defective only when
> 20% of its area is occupied by unstained vacuolar areas
[29,65].
On the other hand, Bartoov et al. [23] emphasised
that whereas a routine morphological examination is
applied to semen samples as a whole, MSOME focuses
only on the fraction of motile spermatozoa. Analysing
only the motile spermatozoa by MSOME can confer an
additional advantage, as it will provide information
regarding the sample fraction with a higher potential for
achieving fertilization and development. Even though
Akl et al. Reproductive Biology and Endocrinology 2011, 9:120
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analyses using other criteria also employ high magnifica-
tion, the characteristics of these procedures (i.e., fixation
and staining) preclude the possibility of obtaining infor-
mation for the motile portion.
In conclusion, the present study suggests that the use of
MSOME for semen evaluation can be a reliable predictor
of the incidence of normal forms in a sperm sample.
Performing MSOME prior to the IUI procedure can repre-
sent a valuable tool to support or contraindicate this rela-
tively inexpensive treatment and ultimately contribute to
the indication of more complex ART procedures, thereby
avoiding a loss of time. The present findings support the
use of high-magnification microscopy both for selecting
spermatozoa and as a routine method for semen analysis
with potential clinical applications.
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